Evaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study

Evaluation of type 2 diabetes treatment with gliclazide modified release in Azerbaijan (the EdiAzer study): Results from a 16-week observational clinical study

Introduction: Type 2 diabetes is a major public health problem across all economic regions. This open-label study collected real-world data on patients presenting with type 2 diabetes in Azerbaijan treated with gliclazide modified release (MR). Materials and Methods: Newly-diagnosed patients uncontr...

Full description

Bibliographic Details
Main Authors: Valeh A Mirzazada, Ramila A Huseynova, Sevil A Mustafayeva, Fidan N Gasimova, Ulviyya Ahmadova, Narmin Ismayilova, Vafa Kerimova, Hagigat Mehdiyeva, Rana Suleymanova, Zahrakhanim Maharramova, Gulnara Iskandarli, Ofeliya Gurbanova, Sariyya Aghayeva, Sabina Malikova, Konul Ismayilova, Khanim Salimkhanova
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Diabetology
Subjects:
azerbaijan
gliclazide modified release
glycemic control
sulfonylurea
type 2 diabetes
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2020;volume=11;issue=3;spage=175;epage=182;aulast=Mirzazada

Internet

http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2020;volume=11;issue=3;spage=175;epage=182;aulast=Mirzazada

Similar Items